Overall, the findings indicated that anti-PCSK9 treatment improved liver fibrosis by regulating hypoxia-induced autophagy in hepatocytes through the AMPK/mTOR/ULK1 signaling pathway (Fig. 8). This evidence concerns the gene ULK1 and Hepatic fibrosis.